Low-Dose Candesartan Enhances Molecular Mediators of Neuroplasticity and Subsequent Functional Recovery After Ischemic Stroke in Rats
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low-Dose Candesartan Enhances Molecular Mediators of Neuroplasticity and Subsequent Functional Recovery After Ischemic Stroke in Rats
Authors
Keywords
Ischemic stroke, Candesartan, Angiotensin type 1 receptor, Neurotropic factor, Neuroplasticity, Functional recovery
Journal
MOLECULAR NEUROBIOLOGY
Volume 51, Issue 3, Pages 1542-1553
Publisher
Springer Nature
Online
2014-08-01
DOI
10.1007/s12035-014-8830-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Immediate Blood Pressure Reduction on Death and Major Disability in Patients With Acute Ischemic Stroke
- (2014) Jiang He et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- High Blood Pressure After Acute Ischemic Stroke Is Associated With Poor Clinical Outcomes
- (2013) Koji Ishitsuka et al. HYPERTENSION
- Postsynaptic density protein (PSD)-95 expression is markedly decreased in the hippocampal CA1 region after experimental ischemia–reperfusion injury
- (2013) Bing Chun Yan et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Guidelines for the Early Management of Patients With Acute Ischemic Stroke
- (2013) Edward C. Jauch et al. STROKE
- Crosstalk between oligodendrocytes and cerebral endothelium contributes to vascular remodeling after white matter injury
- (2012) Loc-Duyen D. Pham et al. GLIA
- Matrix metalloproteinase-3 in the central nervous system: a look on the bright side
- (2012) Inge Van Hove et al. JOURNAL OF NEUROCHEMISTRY
- Progesterone is neuroprotective against ischemic brain injury through its effects on the phosphoinositide 3-kinase/protein kinase B signaling pathway
- (2012) T. Ishrat et al. NEUROSCIENCE
- Angiogenesis
- (2012) Adviye Ergul et al. STROKE
- The Neurorestorative Benefit of GW3965 Treatment of Stroke in Mice
- (2012) Xu Cui et al. STROKE
- The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
- (2011) Else Charlotte Sandset et al. LANCET
- Vascular Protection by Angiotensin Receptor Antagonism Involves Differential VEGF Expression in Both Hemispheres after Experimental Stroke
- (2011) Weihua Guan et al. PLoS One
- Thymosin β4: a candidate for treatment of stroke?
- (2010) Daniel C. Morris et al. Annals of the New York Academy of Sciences
- Progesterone and allopregnanolone attenuate blood–brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases
- (2010) Tauheed Ishrat et al. EXPERIMENTAL NEUROLOGY
- Thrombolysis With Plasmin: Implications for Stroke Treatment
- (2010) V. J. Marder et al. STROKE
- New Insights in the Biology of BDNF Synthesis and Release: Implications in CNS Function
- (2009) M. E. Greenberg et al. JOURNAL OF NEUROSCIENCE
- Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic
- (2009) Zheng Gang Zhang et al. LANCET NEUROLOGY
- Candesartan Augments Ischemia-Induced Proangiogenic State and Results in Sustained Improvement After Stroke
- (2009) Anna Kozak et al. STROKE
- Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats
- (2008) Tauheed Ishrat et al. BRAIN RESEARCH
- Vascular Protection with Candesartan after Experimental Acute Stroke in Hypertensive Rats: A Dose-Response Study
- (2008) W. Kozak et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A new penumbra: transitioning from injury into repair after stroke
- (2008) Eng H Lo NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started